Credentialing Service for your DSCSA Compliance

Legisym is thrilled to be working alongside Spherity to bring the first production level ATP credentialing solution to the industry. With the successful completion of the ATP Credentialing Pilot in 2020 and the joint founding of the Open Credentialing Initiative in early 2021, the Spherity-Legisym partnership is already proving successful in collaboration and forward-thinking.

The Spherity Credentialing Service is the most comprehensive effort to address the upcoming Authorized Trading Partner requirement for DSCSA. rfxcel was impressed to see how seamlessly it integrated with our solution.

TrackTraceRX recent collaboration with Spherity met our objective to offer an Advanced Track & Trace (ATP) solution. Spherity, a partner that not only understood the nuances of secure digital identities was also agile, trustworthy, and compatible to integrate with our existing systems. Spherity team showcased a depth of expertise in the field, which allowed us to swiftly integrate their services without any significant hurdles.

As a VRS solution provider, all we had to do was a simple API call to the digital wallet to either retrieve or verify credentials and some small changes to handle the response from the wallet. All in all, this technology allows us to implement the ATP check to the existing — and established — processes without disruption.

Data is the key ingredient for almost all aspects of DSCSA compliance. Our role is to provide a solution for secure and reliable capture, use and storage of that data—so that our customers can focus on their core operations. Our goal always, is to partner with our pharmaceutical customers on their compliance journey. By combining Spherity’s subject expertise with our leadership in traceability, we provide a swift and easy to integrate route to best practice compliance for our customers.

When using VRS initially, we utilized GLNs to identify a trading partner. We discovered GLNs that were not active or not associated with the requesting entity. GLNs also do not inform about authorized status. Additionally, we had no proof that the provided GLN actually came from the trading partner. This was a compliance gap we had to close.

The pharmaceutical supply chain is entering a critical phase as trading partners prepare for DSCSA compliance in 2023. Integrating credentialing into existing data management or pharmacy IT systems is key to enabling industry adoption and increasing efficiency in an affordable way. Credentials are key to product identifier (PI) verification and product ownership tracing, two key DSCSA requirements starting Nov 27, 2023.

With the integration of CARO in our self-service Cloud-based VRS solution, we provide requesters and responders a one-stop-shop solution to be compliant and ready for the upcoming verification requirements of DSCSA today.